Insider Shareholders with Direct Ownership of Clene Inc. (CLNN)
This section provides a comprehensive overview of the insiders with direct ownership of Clene Inc. (CLNN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Clene Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
General Resonance Llc
> 10% Shareholder |
0 | 474,561 | 15,313,712 $76.4 Million | 7 |
May 01, 2024
Reduced 0.08%
|
| 800,204 | 0 | 800,204 $3.99 Million | 5 |
Jun 26, 2023
Added 28.34%
|
|
| 555,696 | 0 | 575,145 $2.87 Million | 4 |
Nov 14, 2022
Added 23.32%
|
|
| 5,964,780 | 0 | 444,491 $2.22 Million | 29 |
Sep 30, 2024
Added 17.2%
|
|
| 20,783 | 0 | 68,745 $343,037 | 2 |
May 16, 2022
Added 12.7%
|
|
|
Robert Dee Etherington
Chief Executive Officer |
117,396 | 23,483 | 40,149 $200,343 | 4 |
Sep 30, 2024
Added 19.94%
|
| 7,083 | 0 | 39,476 $196,985 | 2 |
Jun 15, 2022
Added 11.24%
|
|
|
Mark Mortenson
Chief Science Officer |
70,594 | 20,247 | 28,949 $144,455 | 3 |
Sep 30, 2024
Added 41.47%
|
| 20,838 | 0 | 20,838 $103,981 | 1 |
Jul 14, 2021
Added 50.0%
|
|
|
Robert Glanzman
Chief Medical Officer |
15,281 | 4,717 | 10,564 $52,714 | 2 |
May 16, 2022
Reduced 30.87%
|